Related Experiment Video
Updated: Sep 21, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.3K
Feature Fusion and Detection in Alzheimer's Disease Using a Novel Genetic Multi-Kernel SVM Based on MRI Imaging and
Xianglian Meng1, Qingpeng Wei1, Li Meng2
1School of Computer Information and Engineering, Changzhou Institute of Technology, Changzhou 213032, China.
Genes
|May 28, 2022
Summary
This study identifies key brain regions and genes associated with Alzheimer's disease (AD) and early mild cognitive impairment (EMCI) using advanced imaging and genetic analysis. The findings highlight novel biomarkers for improved AD detection and understanding.
Area of Science:
- Neuroimaging
- Genetics
- Computational Biology
Background:
- Voxel-based morphometry (VBM) offers subtle insights into Alzheimer's disease (AD) neurobiology.
- Identifying critical brain voxels for classifying AD, early mild cognitive impairment (EMCI), and healthy controls (HC) is crucial for understanding AD mechanisms.
Purpose of the Study:
- To develop a novel method combining MRI and genetic data for identifying important features in AD detection.
- To explore the neurobiological underpinnings of AD by analyzing significant brain regions and genes.
Main Methods:
- Proposed a novel feature construction method using eigenvalues of top Single Nucleotide Polymorphisms (SNPs) from AD-associated genes.
- Developed a genetic multi-kernel Support Vector Machine (SVM) to identify optimal kernel weights and significant features.
- Analyzed feature significance to pinpoint affected brain regions and associated genes.
Main Results:
- Identified key brain regions affected in AD, including the right superior frontal gyrus, right inferior temporal gyrus, and right superior temporal gyrus.
- Discovered significant AD susceptibility genes such as CSMD1, RBFOX1, PTPRD, CDH13, and WWOX.
- Highlighted significant pathways including calcium signaling and cell adhesion molecules.
Conclusions:
- The proposed model demonstrates strong performance and generalization for AD detection.
- The study provides new candidate abnormal brain features and insights into their contribution to AD.
- Findings contribute to a deeper understanding of the neurobiological mechanisms underlying AD.
Related Concept Videos
Alzheimer's Disease: Overview
692
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
692
Alzheimer's Disease: Treatment
270
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
270

